Trial Profile
Paclitaxol (Taxol) for refractory or relapsed acute leukemia in elderly patients, and blast crisis of chronic myelogenous leukemia: a multicenter phase I/II study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 01 Apr 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Chronic myeloid leukaemia; Leukaemia
- Focus Adverse reactions; Therapeutic Use
- 29 Sep 2005 New trial record.